A multicenter study in Italy evaluates the real-world effectiveness and safety of secukinumab in treating giant cell arteritis. The findings contribute valuable data on the drug's performance outside of clinical trials.
real world effectiveness and safety of secukinumab in giant cell arteritis an italian multicentre cohort study
Original title: “Real-world effectiveness and safety of secukinumab in giant cell arteritis: an Italian multicentre cohort study.”